Vasopressor and Inotrope Therapy in Cardiac Critical Care
- PMID: 32281470
- DOI: 10.1177/0885066620917630
Vasopressor and Inotrope Therapy in Cardiac Critical Care
Abstract
Patients admitted to the cardiac intensive care unit (CICU) are often in shock and require hemodynamic support. Identifying and addressing the pathophysiology mechanisms operating in an individual patient is crucial to achieving a successful outcome, while initiating circulatory support therapy to restore adequate tissue perfusion. Vasopressors and inotropes are the cornerstone of supportive medical therapy for shock, in addition to fluid resuscitation when indicated. Timely initiation of optimal vasopressor and inotrope therapy is essential for patients with shock, with the ultimate goals of restoring effective tissue perfusion in order to normalize cellular metabolism. Use of vasoactive agents for hemodynamic support of patients with shock should take both arterial pressure and tissue perfusion into account when choosing therapeutic interventions. For most patients with shock, including cardiogenic or septic shock, norepinephrine (NE) is an appropriate choice as a first-line vasopressor titrated to achieve an adequate arterial pressure due to a lower risk of adverse events than other catecholamine vasopressors. If tissue and organ perfusion remain inadequate, an inotrope such as dobutamine may be added to increase cardiac output to a sufficient level that meets tissue demand. Low doses of epinephrine or dopamine may be used for inotropic support, but high doses of these drugs carry an excessive risk of adverse events when used for vasopressor support and should be avoided. When NE alone is inadequate to achieve an adequate arterial pressure, addition of a noncatecholamine vasopressor such as vasopressin or angiotensin-II is reasonable, in addition to rescue therapies that may improve vasopressor responsiveness. In this review, we discuss the pharmacology and evidence-based use of vasopressor and inotrope drugs in critically ill patients, with a focus on the CICU population.
Keywords: CICU; dopamine; epinephrine; inotrope; norepinephrine; shock; vasopressor.
Similar articles
-
Vasopressor Therapy in the Intensive Care Unit.Semin Respir Crit Care Med. 2021 Feb;42(1):59-77. doi: 10.1055/s-0040-1710320. Epub 2020 Aug 20. Semin Respir Crit Care Med. 2021. PMID: 32820475
-
Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012.Crit Care Med. 2013 Feb;41(2):580-637. doi: 10.1097/CCM.0b013e31827e83af. Crit Care Med. 2013. PMID: 23353941
-
Inotrope and vasopressor therapy of septic shock.Crit Care Nurs Clin North Am. 2011 Mar;23(1):127-48. doi: 10.1016/j.ccell.2010.12.008. Crit Care Nurs Clin North Am. 2011. PMID: 21316572
-
Vasopressor therapy in critically ill patients with shock.Intensive Care Med. 2019 Nov;45(11):1503-1517. doi: 10.1007/s00134-019-05801-z. Epub 2019 Oct 23. Intensive Care Med. 2019. PMID: 31646370 Review.
-
Adrenergic support in septic shock: a critical review.Hosp Pract (1995). 2010 Feb;38(1):62-73. doi: 10.3810/hp.2010.02.280. Hosp Pract (1995). 2010. PMID: 20469626 Review.
Cited by
-
State of Shock: Contemporary Vasopressor and Inotrope Use in Cardiogenic Shock.J Am Heart Assoc. 2023 Aug;12(15):e029787. doi: 10.1161/JAHA.123.029787. Epub 2023 Jul 25. J Am Heart Assoc. 2023. PMID: 37489740 Free PMC article. Review.
-
Urinary Output as a Predictor of Mortality in Cardiogenic Shock: An Explorative Retrospective Analysis.J Clin Med. 2024 Dec 17;13(24):7706. doi: 10.3390/jcm13247706. J Clin Med. 2024. PMID: 39768629 Free PMC article.
-
A CLINICAL PREDICTION MODEL FOR SHORT-TERM PROGNOSIS IN PATIENTS WITH NON-ACUTE MYOCARDIAL INFARCTION-RELATED CARDIOGENIC SHOCK.Shock. 2025 May 1;63(5):706-713. doi: 10.1097/SHK.0000000000002535. Epub 2024 Dec 10. Shock. 2025. PMID: 39665474 Free PMC article.
-
Prediction of Vasoactive-Inotropic Score on Prolonged Mechanical Ventilation in Adult Congenital Heart Disease Patients After Surgical Treatment Combined with Coronary Artery Bypass Grafting.Braz J Cardiovasc Surg. 2024 May 15;39(3):e20230218. doi: 10.21470/1678-9741-2023-0218. Braz J Cardiovasc Surg. 2024. PMID: 38748809 Free PMC article.
-
Dopamine, Immunity, and Disease.Pharmacol Rev. 2023 Jan;75(1):62-158. doi: 10.1124/pharmrev.122.000618. Epub 2022 Dec 8. Pharmacol Rev. 2023. PMID: 36757901 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources